Management of Health Anxiety with Gastrointestinal Issues

Primary Treatment Approach

The American Gastroenterological Association recommends starting with a low-dose tricyclic antidepressant (TCA) such as amitriptyline 10 mg at bedtime, titrating by 10 mg weekly to a target of 30-50 mg nightly, to address both GI symptoms and anxiety simultaneously through gut-brain neuromodulation 1, 2, 3.
Low-dose TCAs are the first-line neuromodulator for this clinical scenario because they rank first among all medications for reducing abdominal pain (relative risk 0.53; 95% CI 0.34-0.83) and effectively target visceral hypersensitivity while providing anxiolytic effects at these doses 2, 3.

Start amitriptyline or nortriptyline at 10 mg at bedtime, and titrate by 10 mg weekly or biweekly based on response and tolerability, with a target dose of 30-50 mg once daily at night 2.
Secondary amines (nortriptyline, desipramine) may have fewer anticholinergic side effects than tertiary amines (amitriptyline, imipramine) 2.

Sedation, dry mouth, dry eyes, and constipation are the most frequent adverse effects, which often diminish with continued use and can be minimized by slow titration 2.

If moderate-to-severe anxiety or depression dominates the clinical picture, switch to an SSRI at therapeutic doses rather than low-dose TCAs, as low-dose TCAs are inadequate for treating mood disorders 1, 5.
SSRIs have less robust evidence for GI symptom relief compared to TCAs, but effectively treat concurrent anxiety disorders while providing some GI benefit 1, 2, 3, 5.

Consider duloxetine 30 mg once daily, titrating to 60 mg, if TCAs are not tolerated or if pain is prominent, as SNRIs have norepinephric effects that provide greater analgesic benefit than SSRIs 2, 3, 5.
Mirtazapine 15 mg once daily (maximum 45 mg) can be used as an alternative, particularly if the patient has poor appetite or insomnia, as it has norepinephric effects with analgesic properties 2, 3.

Explain to patients that these medications work on the gut-brain axis, not because their symptoms are "in their head," but because the enteric nervous system shares neurotransmitters with the brain 2, 3.
Validate that their symptoms are real and physiologic, and discuss expected side effects upfront to reduce medication-related anxiety 1, 2, 4.

Integrate brain-gut behavioral therapies such as cognitive behavioral therapy or gut-directed hypnotherapy alongside medication for optimal outcomes 1, 5.
Refer to a gastropsychologist if the patient shows moderate-to-severe anxiety symptoms, impaired quality of life, avoidance behavior, or motivational deficiencies affecting self-management 1.
Consider dietary modifications with standard dietary advice initially, progressing to a gentle FODMAP approach if GI symptoms are moderate-to-severe, but avoid restrictive diets in patients with severe anxiety as this may worsen health anxiety 1, 5.